1. ScholarBank@NUS
  2. 1. Staff
  3. Staff Publications
Please use this identifier to cite or link to this item: https://doi.org/10.1186/s12943-021-01437-0
DC FieldValue
dc.titleDDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
dc.contributor.authorKizhakeyil, Atish
dc.contributor.authorZaini, Nurmahirah Binte Mohammed
dc.contributor.authorPoh, Zhi Sheng
dc.contributor.authorWong, Brandon Han Siang
dc.contributor.authorLoh, Xinpeng
dc.contributor.authorNg, Aik Seng
dc.contributor.authorLow, Zun Siong
dc.contributor.authorPrasannan, Praseetha
dc.contributor.authorGong, Chun
dc.contributor.authorTan, Michelle Guet Khim
dc.contributor.authorNagarajan, Chandramouli
dc.contributor.authorHuang, Dachuan
dc.contributor.authorLu, Pang Wan
dc.contributor.authorLim, Jing Quan
dc.contributor.authorBarrans, Sharon
dc.contributor.authorOng, Choon Kiat
dc.contributor.authorLim, Soon Thye
dc.contributor.authorChng, Wee Joo
dc.contributor.authorFollows, George
dc.contributor.authorHodson, Daniel J
dc.contributor.authorDu, Ming Qing
dc.contributor.authorGoh, Yeow Tee
dc.contributor.authorTan, Suat Hoon
dc.contributor.authorGrigoropoulos, Nicholas Francis
dc.contributor.authorVerma, Navin Kumar
dc.date.accessioned2022-07-21T05:05:03Z
dc.date.available2022-07-21T05:05:03Z
dc.date.issued2021-10-16
dc.identifier.citationKizhakeyil, Atish, Zaini, Nurmahirah Binte Mohammed, Poh, Zhi Sheng, Wong, Brandon Han Siang, Loh, Xinpeng, Ng, Aik Seng, Low, Zun Siong, Prasannan, Praseetha, Gong, Chun, Tan, Michelle Guet Khim, Nagarajan, Chandramouli, Huang, Dachuan, Lu, Pang Wan, Lim, Jing Quan, Barrans, Sharon, Ong, Choon Kiat, Lim, Soon Thye, Chng, Wee Joo, Follows, George, Hodson, Daniel J, Du, Ming Qing, Goh, Yeow Tee, Tan, Suat Hoon, Grigoropoulos, Nicholas Francis, Verma, Navin Kumar (2021-10-16). DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes. MOLECULAR CANCER 20 (1). ScholarBank@NUS Repository. https://doi.org/10.1186/s12943-021-01437-0
dc.identifier.issn14764598
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/228996
dc.language.isoen
dc.publisherBMC
dc.sourceElements
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectBiochemistry & Molecular Biology
dc.subjectOncology
dc.subjectDDX3X mutation
dc.subjectHematolymphoid malignancy
dc.subjectPrognosis
dc.subjectTumour metastasis
dc.subjectDrug resistance
dc.subjectCYCLIN D1 EXPRESSION
dc.typeArticle
dc.date.updated2022-07-17T12:05:34Z
dc.contributor.departmentDEAN'S OFFICE (MEDICINE)
dc.description.doi10.1186/s12943-021-01437-0
dc.description.sourcetitleMOLECULAR CANCER
dc.description.volume20
dc.description.issue1
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggres.pdfPublished version3.82 MBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.